Mahamaya Lifesciences Limited (BOM:544611)

Mahamaya Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	393.99	39.16	30.15	30.44	13.65
Cash & Short-Term Investments	393.99	39.16	30.15	30.44	13.65
Cash Growth	906.21%	29.89%	-0.98%	122.99%	-
Accounts Receivable	707.6	484.63	283.09	95.28	91.06
Other Receivables	-	2.21	0.89	0.58	0.16
Receivables	852.55	486.83	283.98	95.86	91.23
Inventory	1,411	1,006	516.37	369.52	191.76
Prepaid Expenses	-	1.95	0.92	0.6	0.64
Other Current Assets	7.39	32.77	41.76	43.59	35.96
Total Current Assets	2,664	1,567	873.18	540.01	333.24
Property, Plant & Equipment	288.27	217.4	183.26	177.76	170.58
Other Intangible Assets	142.95	41.21	29.56	35.3	40.62
Long-Term Deferred Tax Assets	-	-	-	-	1.05
Long-Term Deferred Charges	2.73	53.12	31.68	22.48	8.32
Other Long-Term Assets	4.41	4.49	3.3	3.29	3.34
Total Assets	3,103	1,883	1,121	778.83	557.13

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	644.41	550.68	226.58	276.45	165.56
Accrued Expenses	256.53	182.88	41.56	12.7	15.36
Short-Term Debt	871.69	487.55	433.43	115.56	78.73
Current Portion of Long-Term Debt	-	31.2	27.35	25.16	16.13
Current Income Taxes Payable	-	33.57	14.8	9.34	9.21
Other Current Liabilities	58.71	29.6	36.25	37.43	15.17
Total Current Liabilities	1,831	1,315	779.97	476.64	300.16
Long-Term Debt	35.68	61.6	85.48	103	96.79
Pension & Post-Retirement Benefits	-	3.29	2.72	2.27	2.46
Long-Term Deferred Tax Liabilities	12.05	7.07	4.14	1.73	-
Other Long-Term Liabilities	4.43	1.1	0.81	0.8	0.65
Total Liabilities	1,884	1,389	873.11	584.44	400.06

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	234.05	177.66	12.49	12.49	12.49
Additional Paid-In Capital	-	100.31	-	-	-
Retained Earnings	-	216.53	235.24	181.78	144.27
Comprehensive Income & Other	985.25	-0.3	0.14	0.13	0.31
Shareholders' Equity	1,219	494.2	247.86	194.4	157.06
Total Liabilities & Equity	3,103	1,883	1,121	778.83	557.13

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	907.37	580.35	546.26	243.73	191.65
Net Cash (Debt)	-513.38	-541.19	-516.11	-213.28	-178
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-25.88	-31.87	-37.57	-15.53	-12.96
Filing Date Shares Outstanding	21.9	17.77	13.74	13.74	13.74
Total Common Shares Outstanding	21.9	17.77	13.74	13.74	13.74
Working Capital	833.12	251.04	93.21	63.37	33.08
Book Value Per Share	55.67	27.82	18.04	14.15	11.43
Tangible Book Value	1,076	452.99	218.3	159.09	116.44
Tangible Book Value Per Share	49.14	25.50	15.89	11.58	8.48
Land	-	38.54	41.04	41.04	41.04
Buildings	-	111.3	98.38	97.58	94.14
Machinery	-	112.08	81.88	71.05	59.48

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 11, 2026

Data Sources Report a data error